Innovation in the SUS and the national complex [Fernanda De Negri, from the Ministry of Health] -...

Brazil is graduating more doctors than ever, but quality is a concern

Innovation and access to healthcare [Lorice Scalise, president of Roche Farma Brazil] - Futuro Ta...

Como funciona a Nova Política de Câncer - Futuro Explica

FUTURO DEBATE: Corporate Movement for Health, Anvisa, home therapy coverage, and more!

From Television to TikTok: The Challenges of Health Communication

Drauzio Varella: "The SUS does not need to be redesigned" | Futuro Talks #100

High costs limit medical device production in Brazil

Healthcare Discount Cards - Futuro Explica

New technologies are changing the patient journey.

Medical Device Industry [Paulo H. Fraccaro, Director of DeComSaude at FIESP] – Futuro Talks #99

CORTE GDE 02 FS 08/26/19 TALKS98

The Peptide Trend - Futuro Explica

Women's health in transformation - Thinking about the Future

CORTE GDE 01 FS 260812 TALKS98

The Future of Diagnostic Medicine [Jeane Tsutsui, CEO of Grupo Fleury] – Futuro Talks #98

Aging Science Redefines Care - Thinking About the Future

Why China has become a major hub for oncology innovation

The future of oncology

Patients as CEOs of Their Own Health – The Future Explained

Oncology of the future [Antonio Buzaid, oncologist] – Futuro Talks #97

Endocrinology in the Era of New Obesity Treatments - Thinking About the Future #20

The Challenge of Turning Research Into Innovation in Brazil

The Challenges of Chronic Kidney Disease – Talks Online

The Creation of Mexico's SUS - Future Explained

The Future of the Brazilian Pharmaceutical Industry

Pharmaceutical Sovereignty in Brazil [Norberto Prestes, President of Abiquifi] – Futuro Talks #96

How to make advanced therapies accessible to patients?

The History and Next Steps for Hemobrás – Futuro Explica

Social participation, Conitec, and access

Participação social nas decisões de saúde [Catherine Moura, CEO da Abrale] - Futuro Talks #95

A aposta que mudou a trajetória da MV

Innovation and Network Strategy [Gustavo Pinto, Director at Rede Américas] – Futuro Talks Special...

Parliamentary Amendments in Healthcare – Futuro Explica

ASCO 2026: Oncology Highlights - Thinking About the Future

What will the digital health of the future look like?

Data Integration and Healthcare Efficiency [Paulo Magnus, CEO of MV] – Futuro Talks #94

O boom dos GLP-1 manipulados no Brasil

The Future of Diagnostic Medicine [Marcos Queiroz, Director at Einstein] – Futuro Talks Special E...

PDPs: Brazil's bet on producing its own medicine - Futuro Explica

GLP-1 além do emagrecimento

A revolução dos medicamentos GLP-1 [Andressa Heimbecher Soares, endocrinologista] – Futuro Talks #93

Anvisa, pesquisa clínica e o desafio do acesso

Theranostics and the future of radiology [Clarissa Mathias, oncologist] – Futuro Talks Special Ed...

SXSW 2026 and Reflections on Technology – Future Explained

Agência única resolve o acesso à saúde?

IBDs: Challenges and Trends - Future Explains Special Edition

From innovation to therapy access [Christiano Silva, BMS Brazil Manager] – Futuro Talks #92

O espaço dos biossimilares com a queda de patentes

The Future of AI in Radiology [Giovanni Cerri, President of the InRad and ICOS Council] – Future ...

Digital coaching for health: a distant or near dream? – Future Explains

Novo momento da Anvisa [Leando Safatle, diretor-presidente da Anvisa] - Futuro Talks #91

Acesso depende de integração de dados

Real-world data: the revolution that is changing medicine – Future Explained

Acesso à saúde: por que o paciente ainda espera tanto no Brasil?

Indústria farmacêutica e acesso [Andrea Sambati, CEO Boehringer Ingelheim Brasil] Futuro Talks #90

Screen use and obesity are challenges for early childhood - Thinking about the Future

O que está por trás do aumento dos planos

Interoperability in healthcare: new projects with transformative potential – Future Explains

Por que a saúde suplementar não cresce